News

MCI Onehealth Announces Voting Results of 2023 Annual General and Special Meeting of its Shareholders

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESTORONTO, ON, Sept. 21, 2023 (GLOBE NEWSWIRE)…

6 months ago

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of…

6 months ago

Ark-La-Tex Health Center Introduces New Advanced Regenerative Medicine Therapy with Unparalleled Results

TEXARKANA, Ark., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Ark-la-Tex Health Center is now offering a revolutionary new method in healing,…

6 months ago

AVITA Medical to Present at the Cantor Global Healthcare Conference

VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading…

6 months ago

LeMaitre to Present at the 2023 Cantor Global Healthcare Conference

BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present…

6 months ago

LifeStance to Present at the 7th Annual Bernstein Healthcare Services Disruptors Conference

SCOTTSDALE, Ariz., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers…

6 months ago

PHAXIAM Provides Business and Financial Update For the First Half of 2023

PHAXIAM Provides Business and Financial UpdateFor the First Half of 2023 Conference call and webcast (English) on Monday, September 25,…

6 months ago

Humacyte to Present at the Cantor Global Healthcare Conference

DURHAM, N.C., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered…

6 months ago

Adverum Biotechnologies to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to…

6 months ago

Y-mAbs Announces Data to be Presented at the 55th Congress of the International Society of Pediatric Oncology

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (Nasdaq: YMAB), a commercial-stage biopharmaceutical…

6 months ago